BMI, body fat and GLP-1 care: what the number means

A BMI of 30 does not mean 30 percent body fat

BMI stands for body mass index. Its calculation uses weight relative to height, rather than measuring a sample or scan of body fat. CDC’s BMI FAQ explains the calculation and its limits. A BMI value is not a percentage of your body made up of fat.

For a fictional example, Robin reads “BMI 30” in a visit summary and writes “30% body fat” in a tracking app. That changes the meaning of the result. The useful correction is to label the number as BMI, then ask whether a separate body-composition assessment would answer a relevant clinical question. The BMI result itself supplies no body-fat percentage.

A screening measure can be useful without being a complete assessment

CDC describes BMI as a quick, inexpensive screening measure that can be tracked over time. Its limitations do not make every result meaningless. They explain why a clinician considers the number alongside medical history, examination findings and other relevant information.

BMI does not identify how much of a person’s weight is muscle, bone or fat. NIDDK gives examples of how muscularity and age-related body changes can complicate interpretation. A familiar BMI number therefore cannot prove that body composition or health risk has stayed the same.

Waist size adds a different piece of information

Waist circumference describes a measurement around the abdomen. NIDDK explains why fat stored around the abdomen matters for health risk. This gives a clinician information that a height-and-weight calculation does not provide.

A waist measurement still is not a body-fat percentage, and a change in clothing size is not a diagnosis. If your clinician wants waist measurements, ask how to take them consistently and how the results will be interpreted with the rest of your assessment. You do not need to turn every available measurement into a daily target.

A BMI category does not issue a prescription

NIDDK’s medication overview explains that weight-management medicines are not appropriate for everyone with a high BMI. The prescriber considers benefits, side effects, existing conditions, other medicines, family history and cost. A screening number begins part of the evaluation; it does not complete it.

Also clarify what the proposed medicine is intended to treat. A general weight-management screening rule cannot describe every use of every medicine. Do not change an existing prescription because a calculator assigns you a different category; ask the clinician how your current results affect the plan.

Bring a measurement note, not an unlabeled number

HHS recommends preparing health information and questions for a telehealth visit. A short note can prevent BMI, body weight and another measurement from being mistaken for one another. For each result you bring, record:

• The name of the measurement: for example, weight, BMI or waist circumference.
• The value and unit, where applicable, plus when it was measured or calculated.
• Where it came from: a home measurement, a clinic record or a particular report.
• The question you want answered, such as whether it changes what should be monitored.

Connect the numbers to CoreAge Rx’s clinical evaluation

CoreAge Rx’s medical-intake instructions request medical conditions, medicines and allergies, along with identification and photos. The clinician may request more information before deciding about treatment. A submitted photograph or completed form is not a body-composition test or a guarantee of approval.

The service’s product overview lists compounded semaglutide and tirzepatide. These are not FDA-approved products; FDA recommends compounded drugs only when an approved medicine cannot meet a patient’s medical needs. Read our CoreAge Rx review and visit-goals guide to turn the measurements you have into questions about appropriate care.

Common questions

Keep researching

• Set useful goals for the next visit
• What a GLP-1 evaluation needs to establish
• CoreAge Rx service review